Lumexa Imaging Holdings Statistics
Total Valuation
LMRI has a market cap or net worth of $1.10 billion. The enterprise value is $2.00 billion.
| Market Cap | 1.10B |
| Enterprise Value | 2.00B |
Important Dates
The next confirmed earnings date is Tuesday, November 10, 2026, after market close.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LMRI has 96.07 million shares outstanding. The number of shares has increased by 21.22% in one year.
| Current Share Class | 96.07M |
| Shares Outstanding | 96.07M |
| Shares Change (YoY) | +21.22% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 1.33% |
| Owned by Institutions (%) | 39.42% |
| Float | 22.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 14.53 |
| PS Ratio | 1.05 |
| Forward PS | 1.00 |
| PB Ratio | 1.78 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 34.43 |
| P/OCF Ratio | 16.94 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.61, with an EV/FCF ratio of 62.88.
| EV / Earnings | n/a |
| EV / Sales | 1.92 |
| EV / EBITDA | 25.61 |
| EV / EBIT | 55.42 |
| EV / FCF | 62.88 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 1.59.
| Current Ratio | 1.44 |
| Quick Ratio | 1.36 |
| Debt / Equity | 1.59 |
| Debt / EBITDA | 8.87 |
| Debt / FCF | 30.64 |
| Interest Coverage | 0.40 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 2.22% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $240,687 |
| Profits Per Employee | -$6,397 |
| Employee Count | 4,335 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LMRI has paid $11.08 million in taxes.
| Income Tax | 11.08M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 11.11 |
| 200-Day Moving Average | 11.10 |
| Relative Strength Index (RSI) | 57.37 |
| Average Volume (20 Days) | 316,187 |
Short Selling Information
The latest short interest is 1.92 million, so 2.00% of the outstanding shares have been sold short.
| Short Interest | 1.92M |
| Short Previous Month | 2.02M |
| Short % of Shares Out | 2.00% |
| Short % of Float | 8.68% |
| Short Ratio (days to cover) | 5.12 |
Income Statement
In the last 12 months, LMRI had revenue of $1.04 billion and -$27.73 million in losses. Loss per share was -$0.33.
| Revenue | 1.04B |
| Gross Profit | 154.48M |
| Operating Income | 36.12M |
| Pretax Income | -16.65M |
| Net Income | -27.73M |
| EBITDA | 78.17M |
| EBIT | 36.12M |
| Loss Per Share | -$0.33 |
Balance Sheet
The company has $69.71 million in cash and $975.35 million in debt, with a net cash position of -$905.65 million or -$9.43 per share.
| Cash & Cash Equivalents | 69.71M |
| Total Debt | 975.35M |
| Net Cash | -905.65M |
| Net Cash Per Share | -$9.43 |
| Equity (Book Value) | 615.06M |
| Book Value Per Share | 6.40 |
| Working Capital | 78.06M |
Cash Flow
In the last 12 months, operating cash flow was $64.70 million and capital expenditures -$32.86 million, giving a free cash flow of $31.84 million.
| Operating Cash Flow | 64.70M |
| Capital Expenditures | -32.86M |
| Depreciation & Amortization | 42.05M |
| Net Borrowing | -383.66M |
| Free Cash Flow | 31.84M |
| FCF Per Share | $0.33 |
Margins
Gross margin is 14.81%, with operating and profit margins of 3.46% and -2.66%.
| Gross Margin | 14.81% |
| Operating Margin | 3.46% |
| Pretax Margin | -1.60% |
| Profit Margin | -2.66% |
| EBITDA Margin | 7.49% |
| EBIT Margin | 3.46% |
| FCF Margin | 3.05% |
Dividends & Yields
LMRI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -21.22% |
| Shareholder Yield | -21.22% |
| Earnings Yield | -2.89% |
| FCF Yield | 2.90% |
Analyst Forecast
The average price target for LMRI is $17.67, which is 54.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.67 |
| Price Target Difference | 54.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 5.00% |
| EPS Growth Forecast (3Y) | 77.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LMRI has an Altman Z-Score of 0.79 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.79 |
| Piotroski F-Score | 5 |